Ligament cartilage repair

Ligament cartilage repair is a complex physiological process rather than a specific molecular target like a receptor or enzyme. It involves the restoration of structural integrity to damaged articular cartilage or ligamentous tissue through the activation of specialized cells such as chondrocytes and fibroblasts. Because articular cartilage is avascular, it possesses a notoriously limited intrinsic capacity for self-repair, often resulting in the formation of mechanically inferior fibrocartilage instead of hyaline cartilage (StatPearls, 'Cartilage Repair'). Ligament healing involves a structured progression through inflammatory, proliferative, and remodeling phases, heavily regulated by growth factors such as Transforming Growth Factor-beta (TGF-beta) and Bone Morphogenetic Proteins (BMPs) (PubMed, PMID: 23413159). In a pharmacological context, 'Ligament cartilage repair' is considered a therapeutic indication or a biological outcome. Drugs under development for this purpose typically act as agonists for regenerative pathways, such as Fibroblast Growth Factor 18 (Sprifermin), or as inhibitors of degradative enzymes like matrix metalloproteinases (MMPs) to preserve tissue integrity.

Other names

ChondrogenesisLigamentous healingCartilage regenerationConnective tissue repairArticular cartilage repair

Not applicable as this is a physiological process. Therapeutic agents typically target specific growth factor receptors (e.g., FGFR3) or inflammatory cytokines (e.g., IL-1) to promote this process.